Lena Allweiss
- Epidemiology top 1%
- Hepatology top 0.2%
- Molecular Biology
- Infectious Diseases top 5%
- Immunology top 10%
- Co-authors
- Maura DandriTassilo VolzMarc LütgehetmannAnsgar W. LohseJoerg PetersenStephan UrbanKatja GierschTeresa Pollicino
- Topics
- Hepatitis B Virus Studies (58 papers)Hepatitis C virus research (47 papers)Liver Disease Diagnosis and Treatment (28 papers)
- Cited by
- HepatologyEpidemiologyVirology
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Lena Allweiss
62 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Epidemiology 2.5k
- Hepatology 2.1k
- Molecular Biology 387
- Infectious Diseases 369
- Immunology 287
Countries citing papers authored by Lena Allweiss
This map shows the geographic impact of Lena Allweiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena Allweiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena Allweiss more than expected).
Fields of papers citing papers by Lena Allweiss
This network shows the impact of papers produced by Lena Allweiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena Allweiss. The network helps show where Lena Allweiss may publish in the future.
Co-authorship network of co-authors of Lena Allweiss
This figure shows the co-authorship network connecting the top 25 collaborators of Lena Allweiss. A scholar is included among the top collaborators of Lena Allweiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lena Allweiss. Lena Allweiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 18 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 43 | |
| 7 | 6 | |
| 8 | 1 | |
| 9 | 10 | |
| 10 | 60 | |
| 11 | 1 | |
| 12 | 4 | |
| 13 | 59 | |
| 14 | 78 | |
| 15 | 11 | |
| 16 | 95 | |
| 17 | 97 | |
| 18 | a proof-of-concept Phase 2a clinical trial with Hbv/hdv entry inhibitor Myrcludex B : lb-20 | 24 |
| 19 | 247 | |
| 20 | 21 |
About Lena Allweiss
Lena Allweiss is a scholar working on Hepatology, Epidemiology and Virology, having authored 66 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (58 papers), Hepatitis C virus research (47 papers) and Liver Disease Diagnosis and Treatment (28 papers). The work is most often cited by research in Hepatology (2.1k citations), Epidemiology (2.5k citations) and Virology (113 citations). Lena Allweiss has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Maura Dandri, Tassilo Volz, Marc Lütgehetmann, Ansgar W. Lohse, Joerg Petersen, Stephan Urban, Katja Giersch, Teresa Pollicino, Massimo Levrero and Laura Belloni. Their work appears in journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.